iRhythm Technologies (NSDQ:IRTC) yesterday priced a stock offering worth at least $100 million it plans to use in part to fund a co-development deal with Alphabet (NSDQ:GOOGL) life sciences unit Verily. The 1.37-million-share flotation includes a 30-day underwriters option on another 205,000 shares that would add $15 million if exercised in full. The offering is slated to close […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Orchestra BioMed wins CE Mark for BackBeat hypertension neurostim, names CMO
Orchestra BioMed said yesterday that it received the CE Mark for its Moderato implantable pulse generator system for BackBeat cardiac neuromodulation therapy (CNT), just nine days after naming a new chief medical officer. BackBeat therapy is a bioelectronic treatment designed to lower blood pressure while modulating the autonomic nervous system. The Moderato implantable device is […]
Trial will pit Nobles Medical’s PFO tech against Abbott’s for stroke reduction
The FDA has granted Nobles Medical Technologies II approval to conduct a prospective pivotal clinical trial for the expanded indication of patent foramen ovale (PFO) closure for reduction of recurrent ischemic stroke, according to the company. The FDA cleared the NobleStitch EL for cardiovascular suturing in April 2017. It was CE marked in Europe for […]
iRhythm unveils $13m Verily afib deal, readies $100m offering
iRhythm Technologies (NSDQ:IRTC) said yesterday that it inked a deal worth nearly $13 million with Alphabet (NSDQ:GOOGL) life sciences unit Verily to develop AI-based screening, diagnosis and management technology for atrial fibrillation and said it’s readying a stock offering worth $100 million in part to back the collaboration. The deal to integrate Verily’s data analytics into […]
Abbott launches U.S. pivotal trial for TriClip tricuspid repair device
Abbott (NYSE:ABT) said today that it’s launching another study of its TriClip tricuspid valve repair device, this time aimed at winning U.S. regulatory approval. The five-year, 700-patient Triluminate pivotal trial, under an investigational device exemption from the FDA, is the first such study of a transcatheter, non-surgical treatment for patients with severe tricuspid regurgitation, Abbott […]
FDA grants Shockwave Medical breakthrough device label
Shockwave Medical (NSDQ:SWAV) has won breakthrough device designation from the FDA for the sonic pressure-wave system it has developed to treat calcified coronary lesions. The Santa Clara, Calif.-based company’s C2 IVL (intravascular lithotripsy) catheter is designed to improve blood flow to the heart by fracturing problematic calcium using sonic pressure waves to enable stent delivery, deployment […]
ESC Congress: Study shows bariatric surgery can improve cardiac outcomes in Type 2 diabetes
Bariatric or metabolic surgery can significantly lower the risk of major cardiovascular events among patients with Type 2 diabetes and obesity, according to a new clinical study released at the European Society of Cardiology Congress in Paris. The retrospective study followed 13,722 Type 2 diabetes patients who underwent bariatric surgery to lose weight or metabolic […]
ESC Congress 2019: Biotronik beats Abbott at target lesion failure
Biotronik said yesterday that its Orsiro stent tops the Xience stents made by Abbott (NYSE:ABT) when it comes to target lesion failure, according to data from a clinical trial. The randomized, controlled BioSTEMI trial was the first direct comparison between the two drug-eluting stents in patients with acute ST-segment elevation myocardial infarction (STEMI). Biotronik announced […]
Cook Medical relaunches Beacon Tip catheters in Europe
Cook Medical said today that has relaunched its Beacon Tip catheters in Europe, three years after withdrawing them from the market worldwide. The catheters are now available in the UK, Ireland, Norway, Sweden, Finland, Denmark, Germany, Poland, the Netherlands, Luxembourg, Belgium, France, Switzerland, Austria, Hungary, Spain and Italy. Cook said it is working on relaunching […]
Robocath adds $5.5m for R-One robotic stenting platform, taps Goffart as new CEO
Robocath said today that it raised nearly $6 million for the release of its robotic system in European target markets and tapped Boston Scientific (NYSE:BSX) veteran Lucien Goffart to be its new CEO. Rouen, France-based Robocath said it plans to use the $5.5 million (€5 million) in new funds to lay the groundwork for its R-One […]
Philips inks deal with LindaCare to put CRM monitoring into the cloud
Royal Philips (NYSE:PHG) said yesterday that it entered into an agreement with LindaCare to combine its IntelliSpace cardiovascular informatics platform with the latter’s OnePulse cloud-based monitoring system. The combination is intended to improve monitoring of patients with implanted cardiac rhythm management devices. Belgium-based LindaCare’s OnePulse is designed to aggregate data from CRM devices, bringing transmissions from […]